Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Micha Hacohen, Orit Stolar, Matitiahu Berkovitch, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature
Kirsten Müller‐Vahl
Pharmacopsychiatry (2024) Vol. 57, Iss. 03, pp. 104-114
Open Access | Times Cited: 8
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors
Antonia Manduca, Valeria Buzzelli, Alessandro Rava, et al.
Pharmacological Research (2024) Vol. 203, pp. 107176-107176
Open Access | Times Cited: 8
Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
Daryl Efron, Kaitlyn Taylor
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 8, pp. 5430-5430
Open Access | Times Cited: 16
Cannabinoid treatment for the symptoms of autism spectrum disorder
Adi Aran, Dalit Cayam Rand
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 65-79
Closed Access | Times Cited: 6
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 6
Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism
Sarah H. Shrader, Nicholas Mellen, Jun Cai, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer’s Disease
Kamila Gabrieli Dallabrida, Jeane Maria de Oliveira, Ellen Schavarski Chade, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 592-592
Open Access | Times Cited: 5
Clinical Uses of Cannabinoids: What Does the Evidence Say?
Leah Sera, Carrie Hempel‐Sanderoff
(2025), pp. 43-61
Closed Access
Medicinal Cannabinoids in Children: A Scoping Review
Stephanie Samuelraj, Paul Lee‐Archer, Alison Bowers, et al.
Integrative Medicine Reports (2025) Vol. 4, Iss. 1, pp. 9-43
Open Access
Purified cannabidiol leads to improvement of severe treatment-resistant behavioral symptoms in children with autism spectrum disorder
Pablo Sebastián Fortini, Javier J Toibaro, Roberto Caraballo
Pharmacology Biochemistry and Behavior (2025) Vol. 249, pp. 173971-173971
Closed Access
A Systems Biology Approach for Prioritizing ASD Genes in Large or Noisy Datasets
Veronica Remori, Heather Bondi, Mario Airoldi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2078-2078
Open Access
Efficacy and Safety of Cannabinoids for Autism Spectrum Disorder: An Updated Systematic Review
Danilo Assis Pereira, Lídia Cheidde, Mateus Daniel R Megiolaro, et al.
Cureus (2025)
Open Access
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
Patrícia Soares Silva Montagner, Wesley Medeiros, Leandro Cruz Ramires da Silva, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 11
Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials
Martina D’Angelo, Luca Steardo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3603-3603
Open Access | Times Cited: 4
Therapeutic potential of CBD in Autism Spectrum Disorder
João Francisco Cordeiro Pedrazzi, Lucas Hassib, Frederico Rogério Ferreira, et al.
International review of neurobiology (2024), pp. 149-203
Closed Access | Times Cited: 4
Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management
Jeanne Alves de Souza Mazza, Lisiane Seguti Ferreira, Alice de Faria Martins-Vieira, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 686-686
Open Access | Times Cited: 3
Cannabinoids: Emerging sleep modulator
Zhen Xuen Brandon Low, Xin Ru Lee, Tomoko Soga, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115102-115102
Open Access | Times Cited: 7
A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment
Jean-Christophe Quillet, Michael Siani-Rose, R. J. McKee, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review
Bilal Jawed, Jessica Elisabetta Esposito, Riccardo Pulcini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12453-12453
Open Access | Times Cited: 2
Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report
Noa Raz, Iso Heller, Titti Lombardi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Characteristics for Medical Cannabis Treatment Adherence among Autistic Children and Their Families: A Mixed-Methods Analysis
Ayelet David, Orit Stolar, Matitiahu Berkovitch, et al.
Medical Cannabis and Cannabinoids (2024), pp. 1-1
Open Access | Times Cited: 1
Management of sleep disorders in autism spectrum disorder with co-occurring attention-deficit hyperactivity disorder: update for clinicians
Theodore A. Petti, Mayank Gupta, Yuli Fradkin, et al.
BJPsych Open (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Delta9-tetrahydrocannabinol in in vitro models of inflammation and excitotoxicity
Emily Ross-Munro, Esra Isikgel, Bobbi Fleiss
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic review
Emma Wen Dieperink Ibsen, Per Hove Thomsen
Nordic Journal of Psychiatry (2024) Vol. 78, Iss. 7, pp. 553-560
Open Access | Times Cited: 1
Effects of Medical Cannabis Treatment for Autistic Children on Anxiety and Restricted and Repetitive Behaviors and Interests: An Open-Label Study
Ayelet David, Orit Stolar, Matitiahu Berkovitch, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top